ProMEPS: Initiating a New Era of Intelligent Microphysiological Systems for Drug
埃飞电子 2025-11-03
In the contemporary landscape of pharmaceutical research, microphysiological systems are increasingly emerging as a pivotal technology to replace traditional animal experimentation. As a highly biomimetic organ-on-a-chip platform, it can simulate the structure and function of human organs, providing data support for drug screening that more closely approximates authentic human physiological responses.
However, conventional modeling approaches are plagued by operational complexity, poor reproducibility, and low throughput. The advent of the ProMEPS fully automated microphysiological system has revolutionized this paradigm with its high precision, exceptional reproducibility, and high-throughput modeling capabilities.
This system supports the construction of various organ models, including the blood-brain barrier, liver, kidney, skin, and small airway, through fully automated robotic operations that integrate processes from cell seeding to perfusion culture. Users can customize workflows through an intuitive interface, monitor the modeling process in real-time, and ensure tissue barrier integrity through technologies such as TEER monitoring.